Article metrics

Superior weight loss with once-weekly semaglutide versus other glucagon-like peptide-1 receptor agonists is independent of gastrointestinal adverse events

 

Online download statistics by month:

Online download statistics by month: October 2020 to March 2021

AbstractFullPdf
Oct 2020959455
Nov 2020399364201
Dec 202033231483
Jan 202159959484
Feb 202121442122167
Mar 202113041299183
Total48734787773